Life Sciences

Enterome raises €14.5 million in Series C financing round Nestlé Health Science invests alongside existing investors
20 April 2016

Enterome raises €14.5 million in Series C financing round Nestlé Health Science invests alongside existing investors

ENTEROME Bioscience SA, a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome, announces that it has raised €14.5 million in a Series C...

Read the press release
TargEDys develops new microbiome-based solutions for appetite regulation and announces a €5.8M international round of financing to demonstrate product clinical efficacy.
14 April 2016

TargEDys develops new microbiome-based solutions for appetite regulation and announces a €5.8M international round of financing to demonstrate product clinical efficacy.

TargEDys, an innovator in appetite regulation, announces a €5.8M “Series A” fundraising round based on world-leading research from company founders Serguei Fetissov and...

Read the press release
Cambrooke Therapeutics, Inc. Secures Series C Funding Led by Paris-based Seventure Partners
11 April 2016

Cambrooke Therapeutics, Inc. Secures Series C Funding Led by Paris-based Seventure Partners

Cambrooke Therapeutics, Inc. (“Cambrooke”), a global therapeutic nutrition innovator, is pleased to announce the closing of the Series C investment round, led by Seventure...

Read the press release
MaaT Pharma announces €10 million fundraising and pursues the development of the first worldwide autologous microbiotherapy solution
22 March 2016

MaaT Pharma announces €10 million fundraising and pursues the development of the first worldwide autologous microbiotherapy solution

MaaT Pharma, a reference for the microbiome industry, is announcing a significant €10 million fundraising operation within the context of its series A. This will notably...

Read the press release
Seventure invests EUR 1 M (USD 1.25 M) in First Investment Round for MaaT Pharma™
9 January 2015

Seventure invests EUR 1 M (USD 1.25 M) in First Investment Round for MaaT Pharma™

Seventure Partners, one of Europe’s leaders in financing innovation, announces today its investment in MaaT Pharma™, a newly founded French microbiome company. Seventure...

Read the press release

By continuing your browsing on this site, you accept the use of cookies to carry out statistics of anonymous visits. Read more

Authorize Refuse